Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johnson-Pais

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Disease Models & Mechanisms|September 15, 2020
Teleological role of L-2-hydroxyglutarate dehydrogenase in the kidneyGarrett Brinkley, Hyeyoung Nam, Eunhee Shim, et al.
Cancer|May 11, 2016
Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention TrialDouglas K Price, Cindy H Chau, Cathee Till, et al.
BMC Cancer|June 26, 2010
Identification of viral infections in the prostate and evaluation of their association with cancerMargarita L Martinez-Fierro, Robin J Leach, Lauro S Gomez-Guerra, et al.
Plos One|May 9, 2015
Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention TrialCindy H Chau, Douglas K Price, Cathee Till, et al.
Prostate Cancer and Prostatic Diseases|September 13, 2022
Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsyStefan E Eng, Benjamin Basasie, Alfonso Lam, et al.
Cancer Research Communications|September 30, 2024
Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSIJordan P Hartig, Kaitlyn Bejar, Lyndsay E A Young, et al.
Cancer Discovery|September 4, 2014
L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancerEun-Hee Shim, Carolina B Livi, Dinesh Rakheja, et al.
The Prostate|March 21, 2017
Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention TrialDanyelle A Winchester, Cathee Till, Phyllis J Goodman, et al.
The Prostate|January 16, 2016
Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trialDanyelle A Winchester, Bora Gurel, Cathee Till, et al.
The Prostate|June 6, 2015
Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention TrialDanyelle A Winchester, Cathee Till, Phyllis J Goodman, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Disease Models & Mechanisms|September 15, 2020
Teleological role of L-2-hydroxyglutarate dehydrogenase in the kidneyGarrett Brinkley, Hyeyoung Nam, Eunhee Shim, et al.
Cancer|May 11, 2016
Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention TrialDouglas K Price, Cindy H Chau, Cathee Till, et al.
BMC Cancer|June 26, 2010
Identification of viral infections in the prostate and evaluation of their association with cancerMargarita L Martinez-Fierro, Robin J Leach, Lauro S Gomez-Guerra, et al.
Plos One|May 9, 2015
Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention TrialCindy H Chau, Douglas K Price, Cathee Till, et al.
Prostate Cancer and Prostatic Diseases|September 13, 2022
Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsyStefan E Eng, Benjamin Basasie, Alfonso Lam, et al.
Cancer Research Communications|September 30, 2024
Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSIJordan P Hartig, Kaitlyn Bejar, Lyndsay E A Young, et al.
Cancer Discovery|September 4, 2014
L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancerEun-Hee Shim, Carolina B Livi, Dinesh Rakheja, et al.
The Prostate|March 21, 2017
Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention TrialDanyelle A Winchester, Cathee Till, Phyllis J Goodman, et al.
The Prostate|January 16, 2016
Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trialDanyelle A Winchester, Bora Gurel, Cathee Till, et al.
The Prostate|June 6, 2015
Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention TrialDanyelle A Winchester, Cathee Till, Phyllis J Goodman, et al.
Pageof 8